Published in J Leukoc Biol on July 24, 2013
Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice. Toxicol Lett (2014) 0.88
Immunotherapy for solid tumors--a review for surgeons. J Surg Res (2013) 0.83
Murine model of long-term obstructive jaundice. J Surg Res (2016) 0.76
Dendritic Cells Regulate Treg-Th17 Axis in Obstructive Phase of Bile Duct Injury in Murine Biliary Atresia. PLoS One (2015) 0.76
Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets (2015) 0.76
Immunosuppression in liver tumors: opening the portal to effective immunotherapy. Cancer Gene Ther (2016) 0.75
The Inflammatory Cytokine IL-21 is Expressed by Splenic Neutrophils in Response to Transplantation of Allogeneic Cells. SOJ Immunol (2016) 0.75
Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates. Surgery (2016) 0.75
The Impact of Sterile Inflammation in Acute Liver Injury. J Clin Transl Res (2017) 0.75
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med (1999) 16.91
Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 10.53
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol (2007) 7.60
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80
CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science (2009) 6.14
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol (2004) 4.58
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23
The liver as a lymphoid organ. Annu Rev Immunol (2009) 4.03
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology (2007) 2.78
PD-1 signaling in primary T cells. Immunol Rev (2009) 2.66
Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology (2012) 2.58
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation (2002) 2.49
IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A (2007) 2.46
Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol (2007) 2.30
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest (2009) 2.26
Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A (2010) 2.12
Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology (2003) 2.00
Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J Immunol (2005) 1.76
Characterization of time-related changes after experimental bile duct ligation. Br J Surg (2008) 1.60
Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun (2008) 1.57
Role of PD-1 in regulating acute infections. Curr Opin Immunol (2010) 1.51
TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology (2008) 1.45
Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol (2004) 1.39
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol (2010) 1.35
PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer. J Immunother (2012) 1.32
Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage. Gastroenterology (2008) 1.25
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology (2012) 1.25
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. J Viral Hepat (2010) 1.24
PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. J Immunol (2012) 1.24
Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology (2010) 1.12
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. PLoS One (2012) 1.10
Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury. Hepatology (2010) 1.08
Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy (2010) 1.06
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J Immunol (2011) 1.05
Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunol Invest (2009) 0.98
B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses. Gastroenterology (2008) 0.98
Th17 cells: the emerging reciprocal partner of regulatory T cells in the liver. J Dig Dis (2010) 0.97
Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1. Ann Surg (2012) 0.97
Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection. Clin Exp Immunol (2010) 0.95
Biliary obstruction selectively expands and activates liver myeloid dendritic cells. J Immunol (2006) 0.95
CD4 T cells in hepatic immune tolerance. J Autoimmun (2009) 0.95
Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B. Inflamm Res (2010) 0.93
Wound healing in obstructive jaundice. Br J Surg (1984) 0.93
PD-1 regulates neural damage in oligodendroglia-induced inflammation. PLoS One (2009) 0.92
Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology (2005) 0.92
Inflammation-inducing Th1 and Th17 cells differ in their expression patterns of apoptosis-related molecules. Cell Immunol (2011) 0.91
The tyrosine phosphatase SHP-1 dampens murine Th17 development. Blood (2012) 0.86
NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism. J Hepatol (2010) 0.86
Obstructive jaundice and wound healing. Br J Surg (1990) 0.85
Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction. J Immunol (2011) 0.80
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23
Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol (2005) 2.38
Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med (2008) 2.34
Micromedullary thyroid cancer: how micro is truly micro? Ann Surg Oncol (2009) 1.99
Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol (2003) 1.99
In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood (2005) 1.99
Wound bed preparation: a systematic approach to wound management. Wound Repair Regen (2003) 1.97
Regulatory T cell populations in sepsis and trauma. J Leukoc Biol (2007) 1.96
The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med (2008) 1.86
Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum (2006) 1.85
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78
The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol (2002) 1.72
Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol (2003) 1.72
The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock (2007) 1.71
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res (2012) 1.67
Pulmonary contusion causes impairment of macrophage and lymphocyte immune functions and increases mortality associated with a subsequent septic challenge. Crit Care Med (2005) 1.65
Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol (2005) 1.60
NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol (2002) 1.57
Tumor necrosis factor-alpha-stimulated polymorphonuclear leukocytes suppress migration and bactericidal activity of polymorphonuclear leukocytes in a paracrine manner. Crit Care Med (2002) 1.52
Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. Ann Surg Oncol (2007) 1.51
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury. Crit Care Med (2010) 1.49
Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg (2011) 1.48
The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets (2007) 1.47
Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med (2007) 1.47
The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr (2004) 1.45
Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12. J Immunol (2005) 1.43
Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins. Dermatol Surg (2012) 1.41
Carrageenan/MIV-150 (PC-815), a combination microbicide. Sex Transm Dis (2007) 1.40
Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol (2005) 1.40
Protocol for the successful treatment of venous ulcers. Am J Surg (2004) 1.39
Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol (2003) 1.39
Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg (2002) 1.39
CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J Leukoc Biol (2004) 1.34
Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg (2008) 1.33
In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol (2005) 1.32
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood (2007) 1.29
Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med (2008) 1.26
Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care (2012) 1.23
BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction. J Leukoc Biol (2012) 1.22
Autoimmunity associated with immunotherapy of cancer. Blood (2011) 1.22
Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock (2004) 1.22
Stem cells in cutaneous wound healing. Clin Dermatol (2007) 1.21
Gastrointestinal stromal tumors: a spectrum of disease. Surg Oncol (2003) 1.20
Assay for establishing whether microbicide applicators have been exposed to the vagina. Sex Transm Dis (2004) 1.19
Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med (2007) 1.18
Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med (2011) 1.16
Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors. Clin Cancer Res (2010) 1.16
CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am J Pathol (2007) 1.15
CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J (2009) 1.14
A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem (2007) 1.12
Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock (2002) 1.11
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood (2009) 1.11
Anti-inflammatory mechanisms of sepsis. Contrib Microbiol (2011) 1.10
Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol (2003) 1.07
Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol (2004) 1.07
Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury. J Immunol (2009) 1.07
Unusual causes of cutaneous ulceration. Surg Clin North Am (2010) 1.06
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J Immunol (2011) 1.05
Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion. Hepatology (2007) 1.05
Role of activated neutrophils in chest trauma-induced septic acute lung injury. Shock (2012) 1.05
The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock. J Immunol (2009) 1.04
Shock and hemorrhage: an overview of animal models. Shock (2005) 1.04
Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy. Prostate (2004) 1.03
Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation. Clin Cancer Res (2008) 1.03
B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients. Crit Care (2013) 1.03
Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt) (2004) 1.01
Deficiency of gammadelta T lymphocytes contributes to mortality and immunosuppression in sepsis. Am J Physiol Regul Integr Comp Physiol (2006) 1.01
Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome. Am Surg (2008) 1.00
Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Repair Regen (2002) 0.99
Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock (2012) 0.99
The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds. Expert Opin Emerg Drugs (2013) 0.98
The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis. Shock (2011) 0.97
Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice. Am J Pathol (2009) 0.97
Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1. Ann Surg (2012) 0.97
Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen (2015) 0.97
The science of wound bed preparation. Surg Clin North Am (2009) 0.96
Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth. Cancer Res (2006) 0.96
Biliary obstruction selectively expands and activates liver myeloid dendritic cells. J Immunol (2006) 0.95
Genetic disruption of protein kinase Cδ reduces endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2012) 0.95
Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study. Wound Repair Regen (2006) 0.94
Divergent roles of murine neutrophil chemokines in hemorrhage induced priming for acute lung injury. Cytokine (2005) 0.94
Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction. J Surg Res (2003) 0.93
Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: Harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity. J Immunother (2003) 0.93
Basic approach to inflammatory ulcers. Dermatol Ther (2007) 0.93
Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis. Front Biosci (2006) 0.93
Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol. Am J Physiol Endocrinol Metab (2003) 0.91
A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg (2007) 0.91
The science of wound bed preparation. Clin Plast Surg (2007) 0.90
Measurements in wound healing. Int J Low Extrem Wounds (2008) 0.90
Primary biliary B-cell lymphoma of the cystic duct causing obstructive jaundice. Am Surg (2007) 0.90
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunol Immunother (2015) 0.90
Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival. Shock (2010) 0.90